Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Memantine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 8 Glioblastoma 3 Cognitive Dysfunction 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Tobacco Use Disorder 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Motor Activity 1 Melanoma 1 Gliosarcoma 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Epilepsy 1 Ependymoma 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Cancer Pain 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Medical Marijuana 2 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡